Key result
VEGF signaling blockade reduces cardiac allograft arteriosclerotic lesion formation and intimal thickening.
Why the study?
Cardiac allograft arteriosclerosis involves complex interactions including cytokines and growth factors, but the role of VEGF in lesion formation was unclear.
Does VEGF signaling modulate the development of cardiac allograft arteriosclerosis in animal models?
Does VEGF signaling modulate the development of cardiac allograft arteriosclerosis in animal models?
VEGF plays a positive regulatory role in the formation of coronary arteriosclerotic lesions in cardiac allografts, suggesting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
VEGF signaling may promote cardiac allograft arteriosclerosis in animals; leaves open whether receptor blockade could prevent chronic rejection in human recipients.
Background — Cardiac allograft arteriosclerosis is a complex process of alloimmune response, chronic inflammation, and smooth muscle cell proliferation that includes cross talk between cytokines and growth factors. Methods and Results — Our results in rat cardiac allografts established alloimmune response as an alternative stimulus capable of inducing vascular endothelial growth factor (VEGF) mRNA and protein expression in cardiomyocytes and graft-infiltrating mononuclear inflammatory cells, which suggests that these cells may function as a source of VEGF to the cells of coronary arteries. Linear regression analysis of these allografts with different stages of arteriosclerotic lesions revealed a strong correlation between intragraft VEGF protein expression and the development of intimal thickening, whereas blockade of signaling downstream of VEGF receptor significantly reduced arteriosclerotic lesions. In addition, in cholesterol-fed rabbits, intracoronary perfusion of cardiac allografts with a clinical-grade adenoviral vector that encoded mouse VEGF 164 enhanced the formation of arteriosclerotic lesions, possibly secondary to increased intragraft influx of macrophages and neovascularization in the intimal lesions. Conclusions — Our findings suggest a positive regulatory role between VEGF and coronary arteriosclerotic lesion formation in the allograft cytokine microenvironment.
No takes yet. Share an insight, caveat, or question.
Lemström et al. (2002) studied Cardiac allograft arteriosclerosis. Vascular endothelial growth factor (VEGF) / VEGF blockade was evaluated on Arteriosclerotic lesion formation and intimal thickening. Vascular endothelial growth factor (VEGF) expression enhances the formation of arteriosclerotic lesions in cardiac allografts, whereas blockade of VEGF signaling significantly reduces these lesions.
Synapse has enriched 10 related papers. Consider them for comparative context: